Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | IMPA1 |
| Upstream (Parents) |
|---|
| (<<) ADCY6 → IMPA1 |
| (<<) ALDOA → IMPA1 |
| (<<) ALOX15B → IMPA1 |
| (<<) ARAF → IMPA1 |
| (<<) CAV3 → IMPA1 |
| (<<) CLPP → IMPA1 |
| (<<) E2F5 → IMPA1 |
| (<<) ELF1 → IMPA1 |
| (<<) FZD6 → IMPA1 |
| (<<) GNA11 → IMPA1 |
| (<<) GRB7 → IMPA1 |
| (<<) MAP3K5 → IMPA1 |
| (<<) MAPK1 → IMPA1 |
| (<<) MKNK2 → IMPA1 |
| (<<) PABPC3 → IMPA1 |
| (<<) PLCD4 → IMPA1 |
| (<<) RHOV → IMPA1 |
| (<<) SLC25A32 → IMPA1 |
| (<<) VEGFB → IMPA1 |
| Downstream (Children) |
|---|
| IMPA1 → FAM46B (>>) |
| IMPA1 → LDLR (>>) |
| IMPA1 → MAPK8 (>>) |
| IMPA1 → TAF1A (>>) |
| IMPA1 → TCEB1 (>>) |
